All Stories

  1. Plasma Steroid Metabolome Profiling for Diagnosis and Subtyping Patients with Cushing Syndrome
  2. Impairment of Host Liver Repopulation by Transplanted Hepatocytes in Aged Rats and the Release by Short-Term Growth Hormone Treatment
  3. Biochemical investigations in diagnosis and follow up of acromegaly
  4. Substrate Metabolism and Insulin Sensitivity During Fasting in Obese Human Subjects: Impact of GH Blockade
  5. Targeting heterogeneity of adrenocortical carcinoma: Evaluation and extension of preclinical tumor models to improve clinical translation
  6. Spotting the Cheaters
  7. Worsening of lipid metabolism after successful treatment of primary aldosteronism
  8. Paradoxical worsening of lipid metabolism after successful treatment of primary aldosteronism
  9. Macronutrient composition has sex specific effects on the GH-IGF-I axis
  10. Remission, recurrence and control rates in patients with ACTH-dependent Cushing's syndrome- a monocentric, retrospective analysis
  11. Anthropometric factors have significant influence on the outcome of the GHRH-arginine test - establishment of normative data
  12. Sex specific effects of alterations in macronutrient composition on fat accumulation, lipid-synthesis, -transport and -storage
  13. Is steroid profiling using LC-MS/MS useful in the diagnostic work-up of primary aldosteronism?
  14. Quality assurance in the analysis of growth hormone and insulin-like growth factor I in disorders of the somatotropic axis
  15. Mass Spectrometry-Based Adrenal and Peripheral Venous Steroid Profiling for Subtyping Primary Aldosteronism
  16. Clinical validation for the aldosterone-to-renin ratio and aldosterone suppression testing using simultaneous fully automated chemiluminescence immunoassays
  17. Genotype-Specific Steroid Profiles Associated With Aldosterone-Producing AdenomasNovelty and Significance
  18. Obesity in MENX Rats Is Accompanied by High Circulating Levels of Ghrelin and Improved Insulin Sensitivity
  19. Pegvisomant-primed glucagon stimulation test in assessing GH reserve and GH/IGF kinetics in adults suspected of GH deficiency
  20. Growth hormone binding protein – Physiological and analytical aspects
  21. Coexisting Prolactinoma and Primary Aldosteronism: Is There a Pathophysiological Link?
  22. Genetic and Potential Autoimmune Triggers of Primary Aldosteronism
  23. Oxytocin-induced coping with stressful life events in old age depends on attachment: Findings from the cross-sectional KORA Age study
  24. ACTH after 15 min distinguishes between Cushing's disease and ectopic Cushing's syndrome: a proposal for a short and simple CRH test
  25. Lung function tests in 109 acromegalic patients
  26. Pitfalls of Insulin-like Growth Factor-I and Growth Hormone Assays
  27. Prognostic Value of Aldosterone and Cortisol in Patients Hospitalized for Acutely Decompensated Chronic Heart Failure With and Without Mineralocorticoid Receptor Antagonism
  28. CT mapping of the vertebral level of right adrenal vein
  29. Lower morning to evening cortisol ratio is associated with cognitive impairment in men but not women: An analysis of 733 older subjects of the cross-sectional KORA-Age study
  30. Qualitätssicherung der Analytik von Wachstumshormon und Insulin-Like Growth Factor I bei Erkrankungen der somatotropen Achse
  31. Effects of low-carbohydrate, high-fat diets on apparent digestibility of minerals and trace elements in rats
  32. Age Below 40 or a Recently Proposed Clinical Prediction Score Cannot Bypass Adrenal Venous Sampling in Primary Aldosteronism
  33. Expression of prolactin receptor in aldosterone-producing adrenal adenomas
  34. Nutrient regulation of metabolism and endocrine systems: using low-carbohydrate/high-fat diets to dissect macronutrient effects on endocrine systems
  35. Cardiovascular outcome in patients with primary aldosteronism following adrenalectomy and mineralocorticoid antagonist treatment: prospective results of the Munich Conn Center
  36. ARR screening using IDS-iSYS aldosterone and direct renin: effects of medication in essential and renovascular hypertension, Cushing's syndrome and primary aldosteronism
  37. Detection of pheochromocytoma by enzyme immunoassay measurements of plasma metanephrines requires appropriately established upper cut-offs of reference intervals
  38. Blunted Diurnal Cortisol Pattern Is Associated With Frailty: A Cross-Sectional Study of 745 Participants Aged 65 to 90 Years
  39. Performance Evaluation of a Fully Automated Immunoassay for the Detection of Human Growth Hormone on the Elecsys® Immunoassay System
  40. Influence of pre-analytical conditions on the measurement of components of the GH/IGF axis in rats
  41. Aldosterone Excess Impairs First Phase Insulin Secretion in Primary Aldosteronism
  42. Influence of somatic mutations on the lateralization index of adrenal vein sampling in aldosterone producing adenomas
  43. First phase insulin secretion is impaired by aldosterone excess in primary aldosteronism
  44. Low carbohydrate/high fat energy intake decreases estrogen receptor alpha expression in the arcuate nucleus of the rat hypothalamus
  45. Consumption of low-carbohydrate/high fat diets impairs glucose tolerance in rats independent of changes in body composition
  46. Glycosylated linkers to generate long-acting GH tandems
  47. Quality of life in patients with primary aldosteronism: Gender differences in untreated and long-term treated patients and associations with treatment and aldosterone
  48. Prolonged Zona Glomerulosa Insufficiency Causing Hyperkalemia in Primary Aldosteronism after Adrenalectomy
  49. 625 FULLY AUTOMATED CHEMILUMINESCENCE IMMUNOASSAYS FOR RENIN AND ALDOSTERONE
  50. Gender differences in anxiety and depressive symptoms in patients with primary hyperaldosteronism: A cross-sectional study
  51. Low-carbohydrate high-fat diets in combination with daily exercise in rats: Effects on body weight regulation, body composition and exercise capacity
  52. Spontaneous remission of idiopathic aldosteronism after long-term treatment with spironolactone: results from the German Conn’s Registry
  53. Biochemical diagnosis of growth hormone related diseases1)
  54. Labordiagnostik bei Wachstumshormon-assoziierten Erkrankungen/Biochemical diagnosis of growth hormone related diseases
  55. New Detection Methods of Growth Hormone and Growth Factors
  56. Altered Psychobiological Responsiveness in Women With Irritable Bowel Syndrome
  57. An interaction between a neuropeptide Y gene polymorphism and early adversity modulates endocrine stress responses
  58. Commentary on the Endocrine Society Practice Guidelines: Consequences of adjustment of antihypertensive medication in screening of primary aldosteronism
  59. Failure of Urine Dipsticks to Detect Ketosis in Rats
  60. Utilization of a Mutagenesis Screen to Generate Mouse Models of Hyperaldosteronism
  61. Problems with Growth Hormone Doping in Sports: Isoform Methods
  62. Case report: Acromegaly or end-stage renal disease?
  63. Quantification of growth hormone in serum by isotope dilution mass spectrometry
  64. Progress in Primary Aldosteronism
  65. Total Adrenal Volume But Not Testicular Adrenal Rest Tumor Volume Is Associated with Hormonal Control in Patients with 21-Hydroxylase Deficiency
  66. Failure of temozolomide and conventional doses of pegvisomant to attain biochemical control in a severe case of acromegaly
  67. Detecting Growth Hormone Abuse in Athletes
  68. Measurement of human growth hormone by immunoassays: Current status, unsolved problems and clinical consequences
  69. Predicting metabolisable energy in commercial rat diets: physiological fuel values may be misleading
  70. PL2 Consensus with feet of clay? Diagnostic guidelines and GH assay variability
  71. High Prevalence of Reduced Fecundity in Men with Congenital Adrenal Hyperplasia
  72. Risk Factors Associated with a Low Glomerular Filtration Rate in Primary Aldosteronism
  73. Low-carbohydrate High-fat Diets: Regulation of Energy Balance and Body Weight Regain in Rats
  74. Pitfalls of Insulin-Like Growth Factor I Assays
  75. Endokrine Funktionen
  76. Growth Hormone
  77. Altersabhängige Repopularisierung der Rattenleber durch Hepatozyten
  78. Endogenous estradiol may influence IGF-I levels in acromegalic women treated with pegvisomant
  79. Technology Insight: detecting growth hormone abuse in athletes
  80. hGH-abuse in athletes
  81. Increased acylated plasma ghrelin, but improved lipid profiles 24-h after consumption of carob pulp preparation rich in dietary fibre and polyphenols
  82. Growth hormone assays: current methodologies and their limitations
  83. What Endocrinologists Should Know About Growth Hormone Measurements
  84. Diagnostik des primären Hyperaldosteronismus*
  85. Preanalytical Stability of Adrenocorticotropic Hormone Depends on Time to Centrifugation Rather than Temperature
  86. Gastrointestinal signalling peptides in obesity
  87. How Robust Are Laboratory Measures of Growth Hormone Status?
  88. Endokrine Funktionen
  89. Normal Values of Insulin-Like Growth Factor I and Their Clinical Utility in Adults
  90. Endocrinological effects of mirtazapine in healthy volunteers
  91. The influence of mirtazapine on anterior pituitary hormone secretion in healthy male subjects
  92. Doping with Growth Hormone
  93. Acromegaly Caused by Secretion of Growth Hormone by a Non-Hodgkin's Lymphoma
  94. Test method: GH
  95. Dehydroepiandrosterone Replacement in Women With Adrenal Insufficiency
  96. Dehydroepiandrosterone Replacement in Women with Adrenal Insufficiency
  97. Detection of doping with human growth hormone
  98. How to Characterize and Improve Oligonucleotide Uptake into Leukocytes
  99. Growth Hormone and the Immune System
  100. Oligonucleotides: Extrapolating from in vitro to in vivo
  101. Antisense Strategies for Inhibition of Tumor Necrosis Factor-α Synthesis
  102. 11 Endokrinologie
  103. Immunoassay Measurements of Leptin
  104. Measurement of Peptide Hormones